首页期刊导航|科学通报(英文版)
期刊信息/Journal information
科学通报(英文版)
科学通报(英文版)

周光召

旬刊

1001-6538

csb@scichina.com

010-64036120

100717

北京东黄城根北街16号

科学通报(英文版)/Journal Chinese Science BulletinEISCI
查看更多>>《科学通报》创刊于1950年,是中国科学院主办、中国科学杂志社承办的自然科学综合性学术刊物,报道自然科学各学科基础理论和应用研究方面具有创新性和和高水平的、具有重要意义的最新研究成果,要求文章的可读性强,能在一个比较宽范的学术领域产生深刻的影响。我们的目标是:成为国内外读者了解中国乃至世界范围的自然科学各研究领域最新成果的主要窗口之一。《科学通报》进入了国际上主要检索系统,如CA,EI,日本《科技速报》和美国科学信息研究所(ISI)的以下系统:Science Citation Index(SCI-CDE),SCISearch,Current Contents(PC&E)和Research Alert。
正式出版
收录年代

    Structural design of light-emitting fibers and fabrics for wearable and smart devices

    Xiaoxiao YuLinfeng ChenJunyan ZhangWei Yan...
    2439-2455页
    查看更多>>摘要:Flexible light-emitting fibers and fabrics serve to bridge human-machine interactions.The desire for practical applications and the commercialization of flexible light-emitting fibers has accelerated struc-tural progress and improvements.This review focuses on the structural design of light-emitting fibers and fabrics,starting with a summary of design principles,emission mechanisms,and structural evolution of coaxial structured light-emitting fibers.Subsequently,we explore recent advances in the helical struc-ture design strategies that boost the mechanical sensitivity of light-emitting fibers.Following that,we analyze continuous preparation processes and the development of large-area intelligent light-emitting fabrics based on interwoven structures.Examples based on stiff and rigid inorganic-based light-emitting diodes integrated into flexible systems are also presented.Finally,we discuss the current chal-lenges and future opportunities for light-emitting applications in the field of wearable and smart devices.

    Development of T cell antigen-based human coronavirus vaccines against nAb-escaping SARS-CoV-2 variants

    Hao ZhouPing LengYang WangKaiwen Yang...
    2456-2470页
    查看更多>>摘要:Currently approved vaccines have been successful in preventing the severity of COVID-19 and hospital-ization.These vaccines primarily induce humoral immune responses;however,highly transmissible and mutated variants,such as the Omicron variant,weaken the neutralization potential of the vaccines,thus,raising serious concerns about their efficacy.Additionally,while neutralizing antibodies(nAbs)tend to wane more rapidly than cell-mediated immunity,long-lasting T cells typically prevent severe viral illness by directly killing infected cells or aiding other immune cells.Importantly,T cells are more cross-reactive than antibodies,thus,highly mutated variants are less likely to escape lasting broadly cross-reactive T cell immunity.Therefore,T cell antigen-based human coronavirus(HCoV)vaccines with the potential to serve as a supplementary weapon to combat emerging SARS-CoV-2 variants with resistance to nAbs are urgently needed.Alternatively,T cell antigens could also be included in B cell antigen-based vaccines to strengthen vaccine efficacy.This review summarizes recent advancements in research and develop-ment of vaccines containing T cell antigens or both T and B cell antigens derived from proteins of SARS-CoV-2 variants and/or other HCoVs based on different vaccine platforms.